Dysregulation of FOXP3 has been reported in the context of various tumors types indicating that it could be a poor prognostic factor in colorectal cancer and bladder cancer 31, 32, but a potential tumor suppressor gene in breast cancer 33, 34. This evidence concerns the gene FOXP3 and breast carcinoma.